web analytics
4 C
Monday, December 5, 2022



Galectin Runners Bioxytran Inc (OTCMKTS: BIXT) & Galectin Therapeutics (NASDAQ: GALT) Breaking Out

One of the most exciting advances in biotechnology is the galectin inhibitor. Galectins are key proteins implicated in a wide range of chronic diseases....

Navigating through the Galectin Therapeutics (NASDAQ: GALT) Triangle In Search of Therapies

Galectin Therapeutics (NASDAQ: GALT), Galecto Biotech (NASDAQ: GLTO), and BioXyTran Inc. (OTCMKTS: BIXT)—these three companies all currently have market capitalizations under $100 million in...

Latest news